BAY81-8973 Pediatric Safety and Efficacy Trial

Brief description of study

The primary objective is to evaluate the safety and efficacy of the treatment with BAY81-8973 for prophylaxis and treatment of breakthrough bleeds in children with severe hemophilia A.

The secondary objectives are

To assess the safety and efficacy of BAY81-8973 during surgeries.
To assess incremental recovery of BAY 81-8973.
To assess pharmacokinetic parameters in a subset of children. (PTPs and PUPs/MTPs -participation in pharmacokinetic [PK] sampling is voluntary and requires consent).

Clinical Study Identifier: NCT01311648

Recruitment Status: Closed

Brief Description Eligibility Contact Research Team

Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.